Compare Heron Therapeutics Inc (HRTX) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Wynn Resorts, Limited — how do they compare? Heron Therapeutics Inc trades at $0.4 (market cap $68.01M), while Wynn Resorts, Limited trades at $75.33 (market cap $7.75B). The key difference: Wynn Resorts, Limited is far larger — about 114× Heron Therapeutics Inc's market cap, and Wynn Resorts, Limited pays a 1.33% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Wynn Resorts, Limited for 76 Days on average.
| HRTX | WYNN | |
|---|---|---|
Market Cap | $68.01M | $7.75B |
Volume | 1,891,941 | 2,243,813 |
Sector | Health | Consumer Cyclical |
52-Week High | $1.49 | $133.09 |
52-Week Low | $0.27 | $74.97 |
Typical Hold Time | 35 Days | 76 Days |
Enterprise Value | $174.75M | $17.99B |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.4061, up 4.13% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics (-22.52% net margin), analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings call discussions.
HRTX faces significant fundamental challenges with consistent losses and negative ROE, though revenue stability provides some foundation. The strong analyst support suggests potential upside if operational improvements materialize, but high execution risk and cash flow concerns warrant caution for investors seeking near-term profitability.
Wynn Resorts (WYNN) trades at $75.15, up 0.24% on the day, with a bearish technical signal driven by moving averages. The company reported mixed Q2 2026 earnings, beating EPS estimates but showing margin pressure in the U.S. Revenue growth is supported by Macau strength, though high capital expenditure for new projects in the UAE and elevated debt levels present financial risks. Analyst consensus remains strongly bullish with a $132.36 price target, but recent institutional activity shows mixed positioning.
The outlook for WYNN hinges on Macau recovery and successful execution of expansion projects, offering potential upside from current levels. However, risks include rising capex, competitive pressures, and macroeconomic sensitivity. Investors should weigh strong analyst sentiment against fundamental challenges and debt load.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
